Abstract
Background
The ideal management of the super-super obese patient (SSO) is unclear and controversy exists as to the choice of procedure as well as the risk for increased morbidity and mortality. I present my experience of laparoscopic mini-gastric bypass (LMGB) in 16 SSO patients with early follow-up results.
Methods
Review of a prospectively maintained database was performed. All the patients underwent LMGB by a single surgeon (CP). Data collected included demographics, operative time, length of stay, complications, and weight loss. Follow-up data was obtained at office visits in addition to periodic telephone interviews and e-mails. All office follow-up and review of correspondence from Primary Care Physicians (PCP) was managed by the operating surgeon.
Results
Sixteen patients were identified as being SSO and comprise the study group. There were 14 women and two men. Average age was 40 years (27–61). Average weight and BMI were 166 (150–193) and 62.4 (60–73), respectively. All procedures were performed laparoscopically by a single surgeon with no conversion to open. Average operative time was 78 min (41–147 min) and hospital stay was 1.2 days. Intraoperative complications included a liver laceration in one patient and an enterotomy in another. Both were managed laparoscopically. No patients required readmission to the hospital, and there were no major complications or deaths. Weight loss showed a consistent increase over the follow-up period with 2 year results of 72 KG lost or 65% EWL.
Conclusion
Laparoscopic mini-gastric bypass (MGB) is a technically simple and safe procedure in SSO patients. LMGB has the advantages of being a single stage procedure, being easily reversible and revisable in a laparoscopic procedure and does not sacrifice portions of the stomach or implant foreign materials. Weight loss appears favorable in the short term; however, information regarding long-term weight loss, durability, and safety profile in this population will require a greater number of patients and longer follow up.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Vivek NP, DaVee RT, Alverdy JT, et al. Duodenal switch provides superior weight loss in the super-obese (BMI ≥ 50 kg/m2) compared with gastric bypass. Ann Surg. 2006 October;244(4):611–9.
Fazylov RM, Savel RH, Horovitz JH, et al. Association of super-super obesity and male gender with elevated mortality in patients undergoing the duodenal switch procedure. Obes Surg. 2005;15:618–23.
Livingston EH, Huerta SA, Arthur D, et al. Male gender is a predictor of morbidity and age a predictor of mortality for patients undergoing gastric bypass surgery. Ann Surg. 2002;236:576–82.
Regan JP, Inabnet WB, Gagner M, et al. Early experience with two stage laparoscopic Roux en Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;15:861–64.
Ren CJ, Patterson E, Gagner M, et al. Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg. 2000;10:514–23.
DeMaria EJ, Schauer P, Patterson E, et al. The optimal surgical management of the super obese patient: the debate. Surg Innov. 2005;12(2):107–21.
Gould JC, Garren MJ, Boll V, et al. Laparoscopic gastric bypass: risks vs benefits up to two years following surgery in super super-obese patients. Surgery. 2006;140(4):524–29; discussion 529–31.
Farkas DT, Vemulapalli P, Haider A, et al. Laparoscopic Roux en Y is safe and effective in patients with a BMI≥60. Obes Surg. 2005;15(4):486–93.
Rutledge R. Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients. Obes Surg. 2005 Oct;15(9):1304–8.
Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001 Jun;11(3):276–80.
Peraglie C. Mini-gastric bypass in a patient homozygous for factor V Leiden. Obes Surg. 2007;17:104–107
Keidar A, Begleibter N, Chalaila A, et al. Bariatric surgey for high risk patients: first staged laparoscopic biliopancreatic diversion with duodenal switch for severe obesity. IMAJ. 2007;9:616–7.
Obrien PE, Dixon JB. Weight loss and early and late complications—the international experience. Am J Surg. 2002;184:42S–5S.
Weiner R, Wagner D, Bockhorn H. Laparoscopic gastric banding for morbid obesity. J Laparoendosc Adv Surg Tech. 1999;9:23–30.
Suter M, Calmes, JM, Paroz, A, et al. A 10 year experience with laparoscopic gastric banding for morbid obesity: high long term complication and failure rates. Obes Surg. 2006;16:829–35.
Camerini G, Adami G, Marinari GM, et al. Thirteen years of follow-up in patients with adjustible silicone gastric banding for obesity: weight loss and constant rate of late specific complications. Obes Surg. 2004;14:1343–8.
Cottam D, Qureshi FD, Mattar SG, et al. Laparoscopic sleeve gastrectomy as an initial weight loss procedure for high risk patients with morbid obesity. Surg Endosc. 2006;20:859–63.
Silecchia G, Boru C, Pecchia A, et al. Effectiveness of laparoscopic sleeve gastrectomy (first stage of bilio-pancreatic diversion with duodenal switch) on co-morbidities in super-obese high risk patients. Obes Surg. 2006;16:1138–44.
Hamoi N, Anthone GJ, Kaufman HS, et al. Sleeve gastrectomy in the high risk patient. Obes Surg. 2006;16:1445–9.
Lalor P, Tucker ON, Szomstein S, et al. Complications after laparoscopic sleeve gastrectomy. SOARD. 2007;4(1):33–8.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Peraglie, C. Laparoscopic Mini-Gastric Bypass (LMGB) in the Super-Super Obese: Outcomes in 16 Patients. OBES SURG 18, 1126–1129 (2008). https://doi.org/10.1007/s11695-008-9574-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-008-9574-z